VTAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the investor's beginner level, long-term investment preference, and the available data, Catheter Precision Inc (VTAK) is not a strong buy at the moment. The technical indicators are bearish, financial performance shows significant losses, and there are no strong positive catalysts or trading signals to support immediate investment. Holding off on this stock is recommended until there are clearer signs of improvement in financials or technical trends.
The MACD is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 24.705, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. The stock is trading near its support level of 1.41, with resistance at 1.647. Overall, the technical indicators suggest a bearish trend.
The company's LockeT device has received FDA registration and CE Mark approval, and it is being showcased at a major industry event, which could increase visibility and adoption in the medical field.
The company's financial performance is weak, with a significant net income loss (-45.36% YoY) and a sharp EPS decline (-95.55% YoY). Additionally, there are no significant insider or hedge fund trading trends, and technical indicators are bearish.
In Q3 2025, revenue increased by 135.42% YoY to $226,000, but net income dropped to -$2,251,000 (-45.36% YoY). EPS also declined significantly to -1.7 (-95.55% YoY). Gross margin improved slightly to 92.04% (+2.75% YoY). Overall, the financials show growth in revenue but substantial losses in profitability.
No analyst rating or price target data available.
